PCOS is now PMOS: But What Does it Mean for Women's Health?

PCOS is a condition that affects 10 to 13% of women of reproductive age globally.

For a condition that affects a large subset of the population, there was a recent modification which has a huge impact on how PCOS is now viewed and diagnosed.

On the surface, it looks like a change in abbreviation. PCOS to PMOS.

But that change matters, because it now shapes how this condition is understood, diagnosed and talked about.

PCOS, which stood for polycystic ovary syndrome, is now renamed PMOS: polyendocrine metabolic ovarian syndrome. 

But what difference does it actually make?

We did the research and reached out to the medical experts on our team to bring you a deep dive on all things PMOS.

Why was PCOS changed to PMOS?

For a long time, the name polycystic ovary syndrome has not sat comfortably with patients or clinicians. 

It suggests the condition is mainly about cysts on the ovaries. But that is not actually what defines it, and not everyone with PCOS has polycystic-appearing ovaries. 

For a very long time, this mismatch led to confusion, longer diagnosis timelines- with the term PCOS leading to a big gap between what the condition actually was and what the term suggested.

Why rename it to PMOS?

The new name, polyendocrine metabolic ovarian syndrome, tries to correct that. 

It puts the focus back on the bigger picture: hormones, metabolism, ovarian function and the wide-ranging way the condition can show up in the body.

That includes things like irregular ovulation, higher androgen levels, insulin resistance, weight changes, acne, excess hair growth, fertility challenges and longer-term metabolic health risks.

In other words, the condition has always been broader than the word “polycystic” makes it sound.

How was the decision to switch from PCOS to PMOS made?

Here’s the thing: The decision to rename PCOS to PMOS was not made overnight. 

It came out of a 14-year international collaboration through the International PCOS Network, and the final consensus was published in The Lancet. 

The process brought together clinicians, researchers, and people with lived experience of the condition, which mattered because this was not just about finding a more accurate medical label — it was also about making sure the name reflected how the condition actually feels to patients in real life.

That broader input was a big part of why the change carried weight. More than 22,000 survey responses, along with international workshops and input from 56 patient and professional organisations, helped shape the final name. 

The aim was to balance scientific accuracy with patient preference, clarity, cultural relevance, and stigma reduction — because at the end of the day, a medical name isn't just to describe a condition. It influences a lot more than that- such as the time to diagnosis and whether someone feels understood, dismissed, or properly seen.

What does PMOS actually refer to now?

PMOS now refers to the same condition many people have known as PCOS, so this is not a brand-new diagnosis or a sudden change in the science. 

What has changed is the way the condition is described. 

The new name puts the focus on what is actually going on in the body: a polyendocrine condition, meaning several hormonal pathways are involved, along with metabolic effects that can influence insulin response, weight regulation, and long-term cardiometabolic health as well as reproductive health.

That framing matters because many patients do not come in worried about “cysts”, and often that is not the issue they are dealing with at all. 

They come in because their periods are irregular, they are noticing acne or excess hair growth, they may not be ovulating regularly, or they are trying to understand why fertility is becoming part of the conversation. 

PMOS is a better way of describing that bigger picture, because it brings together the hormonal, metabolic and reproductive sides of the condition rather than reducing it to the ovaries alone.

And that matters because a more complete label makes it easier for patients to feel understood, and for clinicians to treat the condition as the complex, long-term health issue it really is.

Should we say PCOS or PMOS?

Right now, probably both.

That keeps the language familiar for patients while the new term becomes part of routine clinical use.

Over the next few years, you’ll also start seeing PMOS appear more widely in medical documents, patient resources and guideline updates- with full adoption expected by 2028.

So while the transition will take time, the direction is clear: this is the name that will gradually shape future clinical conversations- and faster, more accurate diagnoses.

Where Amilis comes in

One of the biggest reasons this name change matters is that it could help make diagnosis more straightforward. 

When a condition is as complex as PCOS/PMOS, that kind of delay can mean multiple GP visits, mixed messages, or months of feeling like something is off without getting a clear answer. 

A more accurate name will not fix the whole system on its own, but it can make appointments more productive and help patients come in with the right information and questions.

That is exactly where Amilis comes in. 

If you’re in the UK, we make it easier to:

• Get support sooner, including access to private GP routes at discounted costs and free consultations where available
• You also get free initial consultations with the best fertility clinics across the UK 

If you’re unsure of where to start, you can also book a free chat with our team or take our personalised quiz to get started.

Whether you have PCOS or are simply trying to understand what PCOS/PMOS means for your fertility, we are here to help you get the right information and the right support without the back and forth or the waiting lists.

At Amilis, what’s mattered the most has always been getting listened to, getting clarity, and getting care at the right time. And we’re committed to doing that- one day at a time ♥️